At McGuireWoods’ 16th annual Healthcare Finance & Growth (HCFG) Conference, panels of healthcare-focused investors and lenders provided insights about the healthcare M&A and debt markets....more
Since mid-2022, the macro acquisition environment has faced the challenges of inflation and increasing interest rates, among a variety of other headwinds. Global deal flow is down from its 2021 peak. Yet, as this white paper...more
The Likely Buyers -
Dental support organizations (DSOs) have become an extremely popular investment vehicle in the past two decades. The DSO business model continues to thrive and grow, in large part because of the vital...more
Private equity investment in healthcare has continued to grow considerably from when we examined various niche investment areas on April 11, 2016, in the article titled “Private Equity in Healthcare – A Review of 15 Niche...more
3/29/2018
/ Acquisitions ,
Health Care Providers ,
Hospitals ,
Investment ,
Investors ,
Life Sciences ,
Medical Devices ,
Pharmaceutical Industry ,
Private Equity ,
Private Equity Firms ,
Private Equity Funds